![Ashley Hall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ashley Hall
Corporate Officer/Principal bij
STRUCTURE THERAPEUTICS INC.
Vermogen: 2 M $ op 31-05-2026
Profiel
Ms. Ashley F.
Hall is a Chief Development Officer at Structure Therapeutics, Inc. Ms. Hall was previously employed as a Chief Development Officer by Reneo Pharmaceuticals, Inc., a Senior VP-Global Regulatory Affairs & Policy by Esperion Therapeutics, Inc., a Vice President-Regulatory Affairs by Amgen Rockville, Inc., a Director-World Wide Regulatory Affairs by MedImmune LLC, a Vice President-Regulatory Affairs by CancerVax Corp., a Vice President-Regulatory Affairs by Micromet, Inc., and a Vice President-Regulatory & Clinical Affairs by Revogenex Ltd. She received her undergraduate degree from the University of California San Diego and a graduate degree from the University of San Diego School of Law.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 19-03-2026 | 155.187 ( 0,11% ) | 2 M $ | 31-05-2026 |
Actieve functies van Ashley Hall
| Bedrijven | Functie | Begin |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Corporate Officer/Principal | 18-09-2024 |
Eerdere bekende functies van Ashley Hall
| Bedrijven | Functie | Einde |
|---|---|---|
| ONKURE THERAPEUTICS, INC. | Corporate Officer/Principal | 13-09-2024 |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Develops therapeutics for cancer | Algemeen Adviseur | 01-05-2012 |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Algemeen Adviseur | 01-08-2009 |
Micromet Inc.
 Micromet Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases | Algemeen Adviseur | - |
CancerVax Corp.
 CancerVax Corp. Miscellaneous Commercial ServicesCommercial Services Researches and develops products for the prevention, treatment, and control of cancer | Algemeen Adviseur | - |
Opleiding van Ashley Hall
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
54
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
CancerVax Corp.
CancerVax Corp. Miscellaneous Commercial ServicesCommercial Services Researches and develops products for the prevention, treatment, and control of cancer | Commercial Services |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Develops therapeutics for cancer | Health Technology |
Revogenex Ltd.
 Revogenex Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of San Diego School of Law
 University of San Diego School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reneo Pharmaceuticals, Inc.
 Reneo Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases | Health Technology |
Structure Therapeutics, Inc.
 Structure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecule therapeutics to treat chronic diseases | Health Technology |
Micromet Inc.
Micromet Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases | Health Technology |
Kies MarketScreener 
